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The MTERF-family is a wide family of proteins identified in Metazoa and plants which includes the known mitochondrial transcription
termination factors. With the aim to shed light on the function of MTERF-family members in Drosophila, we performed the cloning and
characterization of D-MTERF3, a component of the most conserved group of this family. D-MTERF3 is a mitochondrial protein of 323 amino
acids. Sequence analysis in seven different organisms showed that the protein contains five conserved “mTERF-motifs”, three of which include a
leucine zipper-like domain. D-MTERF3 knock-down, obtained by RNAi in D.Mel-2 cells, did not affect mitochondrial replication and
transcription. On the contrary, it decreased to a variable extent the rate of labelling of about half of the mitochondrial polypeptides, with ND1
being the most affected by D-MTERF3 depletion. These results indicate that D-MTERF3 is involved in mitochondrial translation. This role, likely
based on protein–protein interactions, may be exerted either through a direct interaction with the translation machinery or by bridging the
mitochondrial transcription and translation apparatus.
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Mitochondrial transcription termination factors are mono-
meric proteins of about 40 kDa able to bind DNA in a sequence-
specific manner. Three factors have been well characterized in
animal systems: human mTERF [1], sea urchin mtDBP [2] and
Drosophila melanogaster DmTTF [3]. They all share the
capacity to arrest the progression of mitochondrial RNA
polymerase in a bidirectional way, as demonstrated by in vitro
transcription experiments [4–6]. On the other hand, the location
of target sites on mtDNA and the specific role of these factors
seem to be peculiar for each species. HumanmTERF binds DNA
at the 3′ end of the ribosomal gene unit and is thought to be
responsible for an attenuation/termination event that causes the⁎ Corresponding author. Dipartimento di Biochimica e Biologia Molecolare,
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doi:10.1016/j.bbabio.2006.04.026steady-state level of rRNAs to be higher than that of the
downstream mRNAs. The recent discovery of a second binding
site in proximity of the H-strand promoter has suggested a
mechanism of transcription machinery recycling accounting for
the high rate of rDNA transcription [7]. This mechanism could
be associated with post-translational modifications of mTERF
factor; protein phosphorylation was recently reported for rat
mTERF [8]. The sea urchin factor mtDBP recognizes two
mtDNA sequences located in the main non-coding region and at
the ND5/ND6 gene boundary, respectively. In the light of recent
findings, mtDBP seems to be a dual function protein: it
terminates the multiple and partially overlapping transcription
units described in sea urchin mitochondria and negatively
regulates mtDNA replication by acting as a contrahelicase [9].
The Drosophila factor DmTTF recognizes two homologous
sequences onmtDNA that lie at the boundary of clusters of genes
transcribed in opposite direction, namely the boundary ND3/
ND5 and cyt b/ND1. Similarly to the sea urchin homologue,
DmTTF seems to regulate the multiple transcription units
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overall amino acid similarity [3] and belong to a wide family of
proteins identified in several Metazoa and plants but not so far in
fungi [10]. Three mTERF paralogues have been identified in
vertebrates; together with mTERF, they define four subfamilies,
named MTERF1 through MTERF4, which include most of
metazoan MTERF proteins. Sub-families MTERF1, which
comprises the well-known human mTERF, and MTERF2 are
restricted to vertebrates; sub-families MTERF3 and MTERF4
include members belonging also to insects and worms, thus
suggesting that they could represent the ancestral MTERF genes
in Metazoa. MTERF3 is the most conserved group of the
MTERF-family. Although sea urchin mtDBP and Drosophila
DmTTF do not belong to any of those sub-families, they seem to
be evolutionary more close to MTERF1 and MTERF2 than
MTERF3 and MTERF4 sub-families.
With the aim to shed light on MTERF-family components in
Drosophila, we performed the cloning and the characterization
of D-MTERF3. Here we show that D-MTERF3 is a modular
protein and that its knock-down decreases the rate of synthesis
of some mitochondrial polypeptides.
2. Materials and methods
2.1. Cloning of D-MTERF3 cDNA
D-MTERF3 cDNA was obtained by means of PCR amplification on a D.
melanogaster cDNA library from 2–14 h embryos. Primers were CG-For
(ATGTTTTGTTCAGCTCTACGTAA) and CG-Rev (TTATCTCGTTTT-
CAAAAACAAATCA), nt positions 193022–193000 and 191899–191923 of
the genomic sequence (AE003591.4), respectively. The amplification product
(1065 bp) was cloned into the vector pGEMT (Promega) and sequenced.
2.2. Bioinformatics
Multiple alignments were performed with ClustalWat NPS@Web server of
the PBIL (http://npsa-pbil.ibcp.fr) and were formatted with ESPript 2.2. Coiled-
coils were predicted with the program COILS 2.2 [11], using the MTK matrix.
Protein architecture analysis and graphical representation of the ‘mTERF-
motifs‘’ was carried out using the Web tool SMART in Normal mode (http://
smart.embl-heidelberg.de/) and the tool HMM-Logos [12], respectively.
Mitochondrial localization of D-MTERF3 was predicted using PSORT II
Prediction program and MitoProt II [13].
2.3. Drosophila cell culture and conditions for RNAi
Drosophila embryonic cell line D.Mel-2 (GIBCO-Invitrogen) was main-
tained in Drosophila SFM (GIBCO-Invitrogen) supplemented with 16 mM L-
glutamine, 50 units/ml penicillin and 50 μg/ml streptomycin, at 28 °C in 75-cm2
flasks. For dsRNA treatment, the cells were diluted to a final concentration of
1.0×106 cells/ml in 10 ml of complete Drosophila SFM in 75-cm2 flasks.
dsRNA (15 μg per 106 cells) was added directly to the medium to a final
concentration of 30 nM. Flasks were swirled by hand and the cells were
incubated at 28 °C for 1 h. Then, 10 ml of medium were added to obtain a cell
density of 0.5×106 cells/ml, an additional incubation at 28 °C for 72 h followed.
2.4. dsRNA production
The templates for the production of dsRNA were PCR-derived fragments
carrying at both ends the T7 promoter sequence. Each primer used in the PCR
contained a 5′ end sequence corresponding to the T7 polymerase promoter
(TAATACGACTCACTATAGGGA), followed by a gene-specific sequence as
indicated: D-MTERF3 (accession: DQ414686) forward-primer nt 375–391,reverse-primer nt 947–931; odds-paired (accession: NM_079504) forward-
primer nt 270–285, reverse-primer nt 987–972. The PCR products were purified
by the Wizard SV PCR Clean-Up System (Promega) and used as templates for
the MEGAscript T7 transcription kit (Ambion) to produce dsRNA according to
the manufacturer's instructions.
2.5. RT-PCR and Real-Time RT-PCR assays
Total cellular RNA was extracted from treated and untreated D.Mel-2 cells
by the RNeasy Midi Kit (Qiagen). Semiquantitative RT-PCR assay was
performed using the Enhanced Avian HS RT-PCR Kit (Sigma) according to the
manufacturer's instructions. Reactions contained 300 ng of Drosophila total
RNA as template, and 50 pmol of primers specific for D-MTERF3 (CG-For and
CG-Rev, described above) or for 28S rRNA (endogenous control, see below) in
a final volume of 50 μl.
For Real-Time RT-PCR assay, RNA was reverse-transcribed using the
Enhanced AMV Reverse Transcriptase (Sigma), according to the manufac-
turer's instructions. Each reaction was carried out in a final volume of 25 μl
using 250 ng of total RNA and 25 pmol of mtDNA gene-specific primer.
Forward or reverse primer was added to select the sense or antisense
mitochondrial transcripts. Real-Time PCR was performed using the SYBR®
Green PCR MasterMix (Applied Biosystems) and the ABI PRISM 7000
Sequence Detection System (Applied Biosystems). Primers were designed using
the Primer Express 2.0 software (Applied Biosystem) and sequence positions on
D. melanogaster mtDNA (accession: NC_001709) were as follows: COI-for nt
1838–1862, COI-rev nt 1932–1904; COII-for nt 3569–3593, COII-rev nt
3652–3631; ATPase6-for nt 4409–4433, ATPase6-rev nt 4481–4459; COIII-for
nt 5304–5328, COIII-rev nt 5379–5355; ND3-for nt 5698–5717, ND3-rev nt
5767–5746; ND5-for nt 7040–7061, ND5-rev nt 7114–7095; cyt b-for nt
10697–10719, cyt b-rev nt 10766–10748; ND1-for nt 11984–12002, ND1-rev
nt 12056–12034; lrRNA-for nt 12827–12845, lrRNA-rev nt 12906–12887;
srRNA-for nt 14407–14434, srRNA-rev nt 14484–14462. Cytoplasmic 28S
rRNA (accession: M21017) was used as endogenous control; primer sequence
positions were: 28S-for nt 1407–1429, 28S-rev nt 1480–1462.
Each reaction was run in triplicate and contained 1 μl of reverse
transcription reaction (1 μl of a 1:300 dilution was used for 28S rRNA)
along with 200 nM primers in a final reaction volume of 30 μl.
Amplification conditions were: 95 °C for 10 min, then 40 cycles of 95 °C
for 15 s and 60 °C for 1 min. To ensure that only a single product was
amplified, the melting curve analysis was performed; it took an additional
step of 20 min after the Real-Time PCR, and was carried out using the
Dissociation Curves software (Applied Biosystem). All PCR products were
run on a 2.5% agarose gel to confirm specificity. The amplification plots
produced during Real-Time PCR were used to determine the amplification
efficiency for each amplicon with the formula E=10−1/slope. The relative
quantification of target transcripts in RNAi cells compared to untreated
cells, all normalized to 28S rRNA, was performed according to the
equation: R= (ET)
ΔCt,T/(EC)
ΔCt,C [14], where ET is the amplification
efficiency of target gene transcripts; EC is the amplification efficiency of
endogenous control; ΔCt,T and ΔCt,C are the differences between Ct of the
control and Ct of the RNAi sample for target gene transcripts and for
endogenous control, respectively. For each amplicon, the mean ratio value
was obtained from at least four Real-Time RT-PCR assays, using RNA
obtained from independent RNAi experiments. Statistical analysis was
performed using paired two-tailed Student's t test (P<0.05).
2.6. Labelling of mitochondrial polypeptides
D.Mel-2 cell growth and RNAi procedure were performed as described
above. After 3 days of incubation, about 5×106 control and treated cells
were harvested at room temperature, washed twice with methionine-free
Grace's insect culture medium (GIBCO-Invitrogen) and resuspended at
3×106 cells/ml in the same medium containing 200 μg/ml emetine and
100 μg/ml cycloheximide. Redivue™ L-[35S]methionine (specific activity:
1000 Ci/mmol, Amersham Biosciences) was added at a concentration of
300 μCi/ml, then cells were incubated at 28 °C for 90 min. To test the
specificity of mitochondrial protein labelling, control experiments were
performed in the presence of 100 μg/ml chloramphenicol. After incubation,
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D-PBS. Cells were lysed in Laemmli buffer and total cellular proteins
(200 μg/lane) were fractionated on 15–20% exponential gradient polyacryl-
amide SDS gel. After running, gel was fixed in 25% isopropanol and 10%
acetic acid for 30 min and then treated with the Amplify™ Fluorographic
Reagent (Amersham Biosciences) for 20 min. After 16 h exposure, the
protein synthesis products were visualized by Typhoon 8600 Phosphor
Imaging System (Molecular Dynamics) and the quantitative analysis was
performed with ImageQuant 5.2 software (Molecular Dynamics). Statistical
analysis was performed using paired two-tailed Student's t-test (P<0.05).3. Results
3.1. D-MTERF3: a member of the mTERF-family in
Drosophila
A bioinformatic approach, consisting of retrieval tools based
on protein sequence similarity and domain architecture
conservation, revealed the existence in Drosophila melanoga-
ster of three proteins that, in addition to the characterized
mitochondrial transcription termination factor DmTTF, exhibit
similarity with the human factor mTERF. These polypeptides
are annotated in FlyBase GadFly Genome Annotation Database
as CG7175, CG5047 and CG15390, respectively.
CG7175 (560 amino acids), similarly to DmTTF, does
not clearly fall in any of the four sub-families described in
Metazoa by Linder et al. [10]. Evident orthologues of this
protein were found only in Drosophila pseudoobscura and
Anopheles gambiae so that CG7175 seems unique to
insects. Protein CG5047 (354 amino acids) belongs to the
MTERF3 sub-family whose members, identified in worms
through vertebrates, show the highest degree of sequence
conservation. Finally, CG15390 (275 amino acids) is
included into the MTERF4 sub-family that also comprises
members from worms and vertebrates, but displays a lower
degree of conservation.
As a first step in studying the function of the proteins
belonging to mTERF-family in D. melanogaster, we focused
our attention on the most conserved member, CG5047, that
from now on will be named D-MTERF3. As reported in
FlyBase, D-MTERF3 gene is 1156 bp long; it consists of 2
exons and 1 intron and generates a transcript of 1097 nt. We
cloned D-MTERF3 cDNA by means of PCR on a cDNA library
of D. melanogaster. The sequence of the ORF (accession:
DQ414686) differs from that reported in the Drosophila
database because of 6 nucleotide substitutions which give rise
to 5 amino acid changes (V, A, G, S and I instead of L, V, E, P
and K, in position 42, 125, 301, 316 and 431, respectively).
According to MitoProt II and PSORT II analysis, D-MTERF3 is
predicted to localize to mitochondria, with a putative signal
sequence of 31 residues according to the R(−2) rule. Therefore
the predicted mature D-MTERF3 (323 amino acid long) should
have a calculated molecular weight of 37.7 kDa and an
isoelectric point of 8.67.
Fig. 1 shows the Clustal W alignment of the complete
MTERF3 sequences from D. melanogaster and 6 more
organisms belonging to mammals, birds, amphibians, fishes
and nematodes, respectively. The Drosophila protein displays ashorter N-terminal portion, whereas the counterpart in C.
elegans possesses an insertion of about 20 residues in the C-
terminal region. The multiple alignment shows that 42 amino
acid positions are conserved in all the organisms, corresponding
to 9.5% amino acid identity; the similarity among the 7 proteins
is rather uniformly distributed along the molecule with a higher
conservation in the C-terminal region. The analysis performed
using the SMART tool showed for all these proteins a modular
architecture due to the repetition of a motif of about 30 amino
acids, named “mTERF-motif”. In all the organisms analyzed,
MTERF3 contains 5 “mTERF-motifs” (modules 2–6) placed in
corresponding position; a less conserved additional module
(module 1) was identified only in human and mouse. It is
noteworthy that most of the conserved amino acids are placed in
the “mTERF-motifs”; this points to a critical role of this element
for the structure and function of the protein.
Fig. 2A, B shows the multiple alignment of the “mTERF-
motifs” 2–6 and the pattern of sequence conservation
obtained by using the HMM-Logos tool. The most evident
feature is the very high conservation of a proline residue at
position 8. Interestingly, the presence of a leucine or another
hydrophobic amino acid at positions 11, 18 and 25 suggests
the existence of three repeats of leucine zipper-like heptad
X3LX3 inside the “mTERF-motifs” (the residues in the heptad
being designed a–g in Fig. 2B). In particular, inside the
“mTERF-motifs” 2, 3 and 6, the leucine zipper-like heptads
are not interrupted by proline residues in all the organisms
examined. Therefore, MTERF3 appears to contain at least
three leucine zipper-like domains (see Fig. 1). Moreover,
according to the analysis with the COILS program, all the
proteins are predicted to contain at least two sequences able
to form coiled-coil structures in similar positions (not shown).
Interestingly, two of these sequences overlap with the leucine
zipper-like heptads detected in the “mTERF-motifs” 2 and 3.
3.2. Functional characterization of D-MTERF3
To gain information on the role of D-MTERF3, we produced
a knock-down phenotype in D.Mel-2 cultured cells by the RNAi
procedure. Cells were treated for 72 h with a dsRNA
encompassing 573 nt of D-MTERF3 coding sequence. The
depletion of D-MTERF3 mRNA was monitored by RT-PCR
assay using two primers designed so as to produce the entire
coding sequence, and not to amplify the double-stranded
interfering RNA. The level of D-MTERF3 mRNA showed a
decrease of about 80% in cells treated with D-MTERF3 dsRNA
(Fig. 3); the decrease was specific since no effect was obtained
in cells treated with dsRNA containing the sequence of Opa1
gene (mock control).
The molecular effect of D-MTERF3 knock-down on the
mitochondrial metabolism was investigated by measuring the
content of mtDNA and mitochondrial transcripts, and by
analyzing the pattern of mitochondrial protein synthesis.
MtDNA copy number was determined as mtDNA/nDNA ratio
in control and RNAi cells by means of Southern blotting and
Real-Time PCR assays; this analysis revealed that mtDNA
content did not vary significantly (data not shown). To
Fig. 1. ClustalWalignment of the complete sequence of Drosophila melanogaster D-MTERF3 with its orthologue in Homo sapiens (UniprotKB/TrEMBL accession:
Q96E29), Mus musculus (UniprotKB/TrEMBL accession: Q8R3J4), Gallus gallus (Ensembl accession: ENSGALP00000025725), Xenopus tropicalis (UniprotKB/
TrEMBL accession: Q6P619), Danio rerio (UniprotKB/TrEMBL accession: Q6DHJ7) and Caenorabditis elegans (UniprotKB/TrEMBL accession: Q18746). The
multiple alignmentwas performed at NPS@Web server of the PBIL (http://npsa-pbil.ibcp.fr) using theGONNETweightmatrix and formattedwith theWeb tool ESPript
2.2 (http://espript.ibcp.fr). Identical amino acids in all sequences are shaded in black, similar amino acids are bolded. Blue shaded bars below the alignment show the
mTERF-motifs predicted in all species; the open bar indicates the mTERF-motif predicted only inH. sapiens andM. musculus; positions of putative leucine zipper-like
heptads are shown in red above the alignment. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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mitochondrial transcription, we measured the steady-state
level of several mitochondrial transcripts by using Real-TimeRT-PCR. We first determined the relative steady-state
concentration of most of the mitochondrial RNA species in
control cells. The data reported in Table 1 show a remarkable
Fig. 2. (A) Multiple alignment of the conserved “mTERF-motifs”. Initials of species name together with the “mTERF-motif” number (see Fig. 1) are reported to the
left, sequence positions are also indicated. Similar amino acids are bolded, conserved blocks are shaded in yellow. (B) Graphical representation of the aligned
“mTERF-motifs” shown in (A) as sequence logo; the information content of the motifs is expressed in bits. The relative size of the letters is a measure of the relative
frequencies of the amino acids in the given positions; letters are sorted in descending order depending on their probability. The amino acid position in the putative
leucine zippers (a–g) are also indicated.
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mRNAs. In particular, COIII is the most abundant mRNA,
with its level being only 2-fold lower than that of large and
small rRNAs; the less represented mRNAs are COI and ND1,
whose level is about 8-fold less than COIII. These data are in
agreement with early observations by Berthier et al. [15]
based on northern blotting analysis. Then, we determined the
relative concentration in knock-down and control cells of 7
sense and 5 antisense RNAs, namely the (−)strand transcripts
COI, COII, ATPase8/6, ND5-antisense, cyt b, ND1-antisense,
and the (+)strand transcripts lrRNA, ND1, cyt b-antisense,ND5, ATPase8/6-antisense and COI-antisense. The choice of
analyzing antisense transcripts was dictated by the observa-
tion that the knock-down of the termination factor DmTTF
causes in Drosophila cells a general alteration of mitochon-
drial transcription determining decreased and increased levels
of sense and antisense RNAs [16]. Here, we found that the
level of all the analyzed transcripts did not vary significantly
in D-MTERF3 depleted cells with respect to control (not
shown). From these data it can be concluded that D-
MTERF3 depletion did not alter mtDNA and mitochondrial
RNA level.
Fig. 3. D-MTERF3-targeted RNAi in D.Mel-2 cells monitored by RT-PCR.
Total RNA (300 ng) extracted from control cells, and from cells treated
with D-MTERF3 dsRNA (RNAi) or with Opa1 dsRNA (mock) was used as
template in RT-PCR reactions. Samples were run on a 1.5% agarose gel and
stained with ethidium bromide. Nuclear-encoded 28S rRNA was used as
endogenous control.
Fig. 4. Effect of D-MTERF3 depletion on mitochondrial protein synthesis. (A)
Pulse-labelling of mitochondrial polypeptides was performed by incubating
control and RNAi D.Mel-2 cells with L-[35S]-methionine for 90 min in the
presence of emetine and cycloheximide. Total cell lysates (200 μg of proteins)
were fractionated on 15–20% exponential gradient polyacrylamide gel;
following autoradiography, the gel was stained with Coomassie Brilliant Blue
to normalize polypeptide band signals. (B) Histogram showing the quantifica-
tion of polypeptide rate of synthesis in RNAi cells relative to control cells, fixed
as 1-value. Data represent the mean ratio of five independent experiments;
standard deviations are indicated on the top of the bars. Statistically significant
differences (P<0.05) are marked with an asterisk.
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affect the rate of mitochondrial protein synthesis, we
incubated control and RNAi cells with [35S] methionine
for 90 min, in the presence of emetine and cycloheximide,
two specific inhibitors of cytoplasmic protein synthesis.
After protein separation (Fig. 4A), we observed the typical
profile of the mitochondrial-encoded translation products;
ATPase 8 polypeptide was not detected due to its small size.
Protein labelling was specific since it was abolished by the
addition of chloramphenicol, that inhibits mitochondrial
protein synthesis (not shown). A densitometric analysis of
the protein labelling profile in control cells allowed us to
determine the relative labelling of each polypeptide. This
value was divided by the relative concentration of the
respective mRNA so to calculate the translation efficiency of
each mRNA (see Table 2). The data obtained showed a
wide variation covering almost one order of magnitude
between the most efficiently (COI, ND3) and the least
efficiently (COII, COIII) translated mRNAs.
When we compared the profile of mitochondrial
translation products in knock-down and control cells, we
did not observe any qualitative difference. On a quantitative
basis, the rate of labelling of about half of the
mitochondrial polypeptides exhibited a decline in knock-
down cells, which ranged from about 20% for ND4L toTable 1
Level of mitochondrial RNAs in control D.Mel-2 cells
Gene Relative transcript concentration a
COI 2.7
COII 6.5
ATPase6 4.5
COIII 21.0
ND3 4.0
ND5 3.5
cyt b 5.0
ND1 2.8
lrRNA 41.0
srRNA 39.0
a Determined by Real-Time RT-PCR as relative to 28S rRNA.about 45% for ND1 (Fig. 4B). Data concerning the relative
labelling of each polypeptide and the translation efficiency
of each mRNA in D-MTERF3 depleted cells are also
reported in Table 2. In conclusion, the obtained results
indicate that D-MTERF3 depletion affects the rate of
mitochondrial protein synthesis.
4. Discussion
Mitochondrial gene expression in animal cells is regulated at
different levels. Although in some cases modulation of mtDNA
copy number has been described [17], it appears that regulation
takes place mainly at transcriptional level. A plenty of
information has been accumulated concerning transcriptional
Table 2
Rate of translation of mitochondrial mRNAs in control and RNAi D.Mel-2 cells
Polypeptide Relative labelling of
polypeptide product a
Relative efficiency of
mRNA translation b
Control RNAi Control RNAi
COI 2584 2518 4.0 3.9
COII c 1342 1095 0.9 0.7
ATPase6 c 2585 1959 2.4 1.8
COIII c 3990 2886 0.8 0.6
ND3 c 3617 2763 3.8 2.9
ND5 840 825 1.0 1.0
cyt b 1189 1220 1.0 1.0
ND1 c 1170 696 1.8 1.0
a Determined after a 90 min 35S-methionine pulse, expressed as band intensity
(see Materials and methods) and normalized with respect to methionine content.
b Calculated by dividing the relative labelling of each polypeptide by the
relative concentration of the respective mRNA. The obtained results were
normalized to cyt b value.
c Polypeptides exhibiting a statistically significative variation (P<0.05) of
mRNA translation efficiency between control and RNAi cells.
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initiation via the protein factors TFAM and TFB1/2M. TFAM
binds specifically to mitochondrial promoters and activates
transcription [18,19], moreover, it behaves as a histone-like
protein in mtDNA maintenance [20]. While TFB2M seems to
act as specific transcription initiation factor, TFB1M is involved
in transcription activation and in the modification of rRNA as it
possesses an RNA methyltransferase activity [19,21]. It has
been recently reported that knock-down of TFB1M in
Drosophila cells affected translation but not transcription or
replication [22]. Transcription is regulated also at termination
level by means of protein factors which have been shown to
arrest RNA synthesis in vitro [1–6]. We have recently found
that depletion of DmTTF, the Drosophila termination factor,
causes a general alteration of the mitochondrial transcript
pattern, thus suggesting an involvement of this factor in
transcription termination as well as in transcription initiation
[16]. Regulation of mtDNA transcription in Drosophila seems
to occur also at post-transcriptional level. As reported in Table
1, the abundance of mitochondrial transcripts shows a wide
variation. In particular, there is an about 7-fold difference
between the level of COIII and COI mRNAs that belong to the
same transcription unit; this likely depends on the different
stability of these transcripts. The value of the mitochondrial
rRNA/mRNA ratio in Drosophila is the lowest found in animal
organisms.
Besides the known regulatory factors, other still unknown
proteins could be involved in the regulation of mitochondrial
gene expression. The mTERF-family is a protein family that
includes the mitochondrial transcription termination factors and
several paralogues whose function is still unknown [10]. The
multiplicity of these proteins might be related to the complex
panorama of regulation of the mitochondrial gene expression.
To gain information on the possible regulatory function of those
protein factors, we studied MTERF3, the most conserved
member of the mTERF-family, using Drosophila as a model
system. We applied RNAi procedure to obtain a knock-downphenotype for D-MTERF3 and tested whether protein depletion
could affect mitochondrial gene expression.
Our results indicate that D-MTERF3 should not be
directly involved in mitochondrial replication since mtDNA
copy number is not affected by its depletion. Moreover, the
careful analysis performed on sense and antisense transcripts
scattered along the mtDNA molecule revealed no significant
changes in knock-down cells. On this basis, we tend to rule
out a direct involvement of D-MTERF3 in transcription.
Interestingly, the protein knock-down exerts a depressing
effect on mitochondrial translation, decreasing to a variable
extent the translation rate of half of the mitochondrial
mRNAs. Since D-MTERF3 depletion does not alter the
level of ribosomal and messenger RNAs, it is very likely
that the decrease in the protein synthesis rate reflects a
direct role of the protein in the mitochondrial translation
process.
Regulation at translational level has been described in
different systems. Protein synthesis efficiency was found to
depend on the availability of mRNAs in rat brain synapto-
somes [23] and on the translation rate of mitochondrial
mRNAs in human [24]. The latter situation seems to occur
also in Drosophila where we observed a wide variation in
mRNA translation efficiency covering almost one order of
magnitude. The mechanisms that control translational effi-
ciency in human are not well known. In yeast it has been
reported that the translation of individual mRNAs depends on
the interaction of activating factors with ribosomal proteins or
with the 5′ UTR region of mRNAs [25]. None of these
factors has been identified in animal mitochondria, where
mRNAs lack a 5′ non-coding region and mitochondrial
initiation factors seem to interact with the 5′ coding portion of
the mRNAs [26]. Interestingly, ND1 mRNA, whose transla-
tion is the most affected by D-MTERF3 depletion, has the
longest (10 nt) 5′ non-coding sequence, as predicted by the
mtDNA sequence analysis; this non-coding region might be a
signal for the binding of translation regulatory factors. In
addition to mechanisms regulating the single steps of
mitochondrial gene expression, there is growing evidence
pointing to a functional coupling between transcription and
translation [27]; this should take place through the action of
proteins that bridge the transcribing mitochondrial RNA
polymerase with the membrane-bound translational apparatus.
The effect of D-MTERF3 depletion on mitochondrial
translation might be explained hypothesizing that this protein
plays a role in these regulatory mechanisms. D-MTERF3 may
control mitochondrial translation by means of protein–protein
interactions, as supported by the inspection of its primary
structure. In fact, sequence analysis of D-MTERF3 and its
orthologues reveals the existence of leucine zipper-like
domains, including three heptads, inside the “mTERF-motifs”.
These domains could be involved either in intra-molecular
interactions, needed by the protein to assume the functionally
active conformation, or in homologous or heterologous
dimerization. Further studies on the role of D-MTERF3 in
mitochondrial metabolism are under way and should
contribute to shed light on these hypotheses.
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